Ticker Hub
FENC — AI Analysis & Sentiment
3 recent AI-generated analyses for FENC. Sentiment and confidence insights updated continuously.
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Fennec Pharmaceuticals achieved robust sales growth for its key product, PEDMARK, in Q4 and full-year 2025, and significantly strengthened its bala...
Mar 24, 2026Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation
Fennec Pharmaceuticals has significantly de-risked its core business by settling patent litigation, ensuring market exclusivity for PEDMARK until a...
Mar 16, 2026Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
Fennec Pharmaceuticals' collaboration with Tampa General Hospital could strengthen PEDMARK's adoption and expand its market reach.
Mar 4, 2026